
Pfizer oral pill for Covid-19 gets US FDA approval
Company to increase production of Paxlovid from 80 million to 120 million courses of treatment in 2022; plans to launch worldwide with voluntary licenses to other manufacturers
Company to increase production of Paxlovid from 80 million to 120 million courses of treatment in 2022; plans to launch worldwide with voluntary licenses to other manufacturers
Almost every major Indian pharmaceutical company, including Cipla, Dr Reddy’s, Sun Pharma and Biocon, are on the list of companies which can produce mRNA Covid-19 vaccines
Pfizer's Paxlovid shows 90% efficacy, while much hyped MSD's Molnupiravir is less effective.
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
US company gives voluntary licence to the Medicines Patent Pool for supply to 95 low and middle income countries.
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
At a time when the entire world is frantically trying to procure more vaccine doses, it is going to be a protracted struggle for India.
The Covid-19 pandemic has amplified the importance of cold-chain infrastructure, and Godrej Appliances’ medical refrigeration business is making the most of the opportunity.
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
Godrej & Boyce has built an array of made-in-India ultra-low temperature freezers for the world.